**Question:** Induction agent of choice in a child with cyanotic heart disease

**Core Concept:** Cyanotic heart disease refers to congenital heart defects that cause deoxygenated blood to reach the systemic circulation, resulting in cyanosis (bluish discolouration of the skin). Induction agents are drugs used to induce general anaesthesia in patients undergoing surgery. The choice of induction agent is crucial in these patients to ensure safe and effective anaesthesia while minimizing potential complications.

**Why the Correct Answer is Right:**

**Correct Answer: D. Propofol (Diprivan)**

Propofol is a highly lipophilic, intravenous anaesthetic agent that rapidly induces unconsciousness, amnesia, and muscle relaxation. It has several advantages in the context of cyanotic heart disease:

1. **Low cardiovascular side effects:** Propofol has minimal cardiovascular side effects, such as hypotension, bradycardia, and arrhythmias, which are common in patients with cyanotic heart disease due to reduced cardiac output and hypovolemia.
2. **Improved oxygenation:** Propofol's minimal cardiovascular side effects prevent worsening of cyanosis by minimizing hemodynamic instability and reducing the need for supplemental oxygen.
3. **Faster recovery:** Propofol's rapid induction and recovery profile reduces the duration of anaesthesia and minimizes the risk of hypoxia and desaturation in patients with cyanotic heart disease.

**Why Each Wrong Option is Incorrect:**

**Option A: Sevoflurane (Sevoflo):**
Sevoflurane is a volatile anaesthetic agent that has a higher risk of cardiovascular side effects, hypotension, and bradycardia due to its vasodilatory and chronotropic effects. It may exacerbate the cyanosis and hypovolemia in cyanotic heart disease patients.

**Option B: Thiopentone (Pentothal):**
Thiopentone, a barbiturate, is associated with significant cardiovascular side effects like hypotension, bradycardia, and respiratory depression. It may worsen the cyanosis and hypovolemia in cyanotic heart disease patients.

**Option C: Desflurane (Desflo):**
Desflurane is a volatile anaesthetic agent with similar cardiovascular risks to sevoflurane, increasing the likelihood of hypotension, bradycardia, and worsening cyanosis in cyanotic heart disease patients.

**Option D: Ketamine (Lidocaine):**
Ketamine is a dissociative anaesthetic agent with minimal cardiovascular effects, making it suitable for patients with cyanotic heart disease. However, it can cause hypertension in some cases, which is not ideal for these patients.

**Option E: Midazolam (Dormicum):**
Midazolam is a benzodiazepine with minimal cardiovascular side effects, making it a reasonable choice for cyanotic heart disease patients. However, its sedative effect could lead to hypoventilation, which would not be ideal in these patients.